Incidental discovery of an adrenal mass without clinical manifestations has been increasing due to the development of imaging techniques such as computed tomography (CT) and ultrasonography (US). Geelhoed and Druy (1982) first named such adrenal masses"adrenal incidentaloma" in patients with no signs and symptoms suggestive of adrenal lesion. However, at present, such a disease entity and indications for surgical removal are controversial. We have examined 7 patients with adrenal masses which were incidentally discovered with imaging procedures, and the pathological characteristics were finally confirmed. Their sizes ranged from 1.5 to 5.0 cm including a 2.8 cm cortical carcinoma (Table 1) . Both clinically and biochemically, there was no active hormone excess of glucocorticoids, mineralocorticoids, sex hormones or catecholamines. Using image diagnosis with CT, US, adrenocortical scintigraphy and magnetic resonance images (MRI), we could not tell whether these masses were benign or malignant.
From this experience, in order to clarify the indication for operative removal of an incidentally discovered adrenal mass, we analyzed the"asymptomatic adrenal masses"reported in Japan during the past 25 years dividing it into two periods, before 1979 and after 1980.
Analyzed Patients and Methods
In the present study, we defined asymptomatic adrenal tumors as the adrenal masses which were incidentally found in patients who had no symptoms or signs suggestive of excessive secretion of active adrenal hormones such as glucocorticoids, mineralocorticoids, sex steroids, or catecholamines. We carefully collected only the cases which satisfied the definition given above among the total of 460 Japanese patients with adrenal tumors in the literature ). Even when the terms " non-active ", and " incidentally discovered " were used in the titles of case reports, not a few patients were excluded for the following reasons: 1) they were found to have symptoms and signs suggestive of active hormone excess, 2) the masses were incidentally discovered during abdominal operation or autopsy, 3) they had other adrenal disorders with signs and symptoms of active hormone excess, 4) they had extra-adrenal pheochromocytomas or pheochromocytomas accompanied with multiple endocrine adenomatosis, and 5) their case reports provided little information to make a clear diagnosis possible. However, the patients who had no signs or symptoms of active hormone excess but were found to have hypersecretion of active hormone after the discovery of an adrenal mass were included in this study. We eventually accumulated a total of 379 patients, who were subjected to the present study. The references for these 379 patients (Group A and Group B) and 81 other patients excluded from the study (Grup C) are shown in the APPENDIX with the number. Since whole unable to characterize asymptomatic cortical tumors. In this study, however, myelolipoma was found to be similarly low-dense to fat in CT and high-echoic and multilobular in US as reported by Vick et al. (1984) . Adrenal cyst showed a fluid-filled sac image in CT and US. These image characteristics are useful for pre-operative diagnosis of such adrenal tumors. On the use of 131I-iodocholesterol scintigraphy on cortical tumors, no convincing information could be obtained on tumor classification. Since hypervascularity, vascular encasement, and irregular tumor staining on angiography were sometimes seen even in patients with cortical adenomas in this series, the utility of angiography in differential diagnosis appeared to be limited. CT and US images and the angiographic image characteristics of ganglioneuroma and hemangioma were not always useful in the differentiation between cortical adenoma and carcinoma. (1988) . Therefore, preoperative differentiation of adrenocortical carcinoma from cortical adenoma, adrenal ganglioneuroma, and adrenal hemangioma by means of the above procedures was not always possible. Since large adrenal masses were more likely to be malignant as shown in this study, surgical removal should be the choice of therapy. In 176 patients reported since 1980, 84% (32) of 38 cortical carcinomas were larger than 6 cm in diameter and 90% (34) were larger than 3 cm. According to our estimation, if all tumors larger than 3 cm were operated on, 56% of the adenomas will be operated on but 10% of the carcinoma is left unoperated on. Copeland 
